Golden Cross event and heavy insider buying on GALT
- Golden Cross formed
- CEO takes 80% pay in stock
- Billonaire chairman provided financing
- Developing the leading drug candidate for advanced liver disease
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。